Full course description
Modality: Online - self paced
Duration: This course will require approximately 6 hours of your time.
Price: $100.00 incl. GST
This short course is a recording from the 2025 Ocular Therapeutics Conference with awarded CPD points valid until September 2026. Participants will be able to watch the recordings and listen to the panel discussions in their own time before reflecting on the content.
Short course structure and topics covered:
Each module is 1.5 hours long and comprises 4-5 talks as well as a panel discussion (15 minute each).
|
OTOM1 – Common ocular therapeutics – What is new? |
||
|
Talk title |
Speaker |
Duration |
|
Incorporating the latest TFOS DEWS III recommendations in the clinical management of dry eye disease |
Jennifer Craig |
15 min |
|
Scratching more than the surface - Ocular allergy therapeutics |
Jay Meyer |
15 min |
|
Glaucoma therapeutics - Preservative-free drops and new drug classes |
Hussain Patel |
15 min |
|
Anti-inflammatories and immunomodulators |
Rachael Niederer |
15 min |
|
Recurrent corneal erosion syndrome - What’s new? |
Sue Ormonde |
15 min |
|
Panel discussion |
chair + speakers |
15 min |
|
|
|
|
|
OTOM2 – Hot topics in ocular therapeutics |
||
|
Talk title |
Speaker |
Duration |
|
A bioengineered cornea: Are we there yet? |
Gerard Sutton |
30 min |
|
Light-based ocular therapeutics |
Simon Dean |
15 min |
|
Gut microbiome and eye diseases |
Rachael Niederer |
15 min |
|
Hormone imbalances and the ocular surface |
Stuti Misra |
15 min |
|
Panel discussion |
chair + speakers |
15 min |
|
|
|
|
|
OTOM3 – Inflammation & Therapeutics |
||
|
Talk title |
Speaker |
Duration |
|
Inflammatory retinal disorders – More than steroids |
Jo Sims |
30 min |
|
Treatment of cystoid macular oedema post cataract surgery |
Charles McGhee |
15 min |
|
COVID vaccination and transplant rejections |
Natalie Allen |
15 min |
|
Therapeutics for childhood inherited diseases |
Sarah Hull |
15 min |
|
Panel discussion |
chair + speakers |
15 min |
|
|
|
|
|
OTOM4 – What difference have therapeutics made to clinical practice? |
||
|
Talk title |
Speaker |
Duration |
|
Atropine and more |
Rasha Al-Taie |
15 min |
|
Antibiotics and antivirals |
Kieran O'Kane |
15 min |
|
Therapeutic lenses - From bandage lenses to drug carriers |
Dian Zhuang |
15 min |
|
Crosslinking |
Mo Ziaei |
15 min |
|
BOTU therapeutics - A 10-year journey |
Ilva Rupenthal |
15 min |
|
Panel discussion |
chair + speakers |
15 min |
Learning outcomes:
- OTOM1 - To learn about new therapeutics in the area of dry eye disease, ocular allergies, glaucoma, anti-inflammatories and immunomodulators.
- OTOM2 - To learn about exciting developments in the area of bioengineered corneas, light-based therapeutics as well as the effects of the gut microbiome and hormone imbalances on ocular conditions.
- OTOM3 - To learn about inflammatory eye conditions and their treatment as well as therapeutics for childhood inherited diseases.
- OTOM4 - To learn about different classes of therapeutics that have made a difference to clinical practice.
Who should attend? :
This course is a not-for-profit postgraduate opportunity brought to the New Zealand eye-care community by the Buchanan Ocular Therapeutics Unit. It has been designed for optometrists, ophthalmologists, pharmacists and senior optometry and ophthalmology trainees.
Payment for short courses is normally by credit card. If you need to pay by invoice or require assistance, please email shortcourses@auckland.ac.nz. Please note that the University does not issue individual invoices for amounts less than $500 New Zealand dollars.
By enrolling in a Short Course at the University of Auckland you agree to the Short Course Terms and Conditions